Skip to main content
logo
Halozyme Therapeutics, Inc. (HALO)
NASDAQ: HALO · Real-Time Price · USD
76.33
-0.57 (-0.74%)
At close: Sep 15, 2025, 4:00 PM EDT
75.00
-1.33 (-1.74%)
After-hours: Sep 15, 2025, 6:03 PM EDT

Halozyme Therapeutics Market Cap

Halozyme Therapeutics has a market cap or net worth of $8.93 billion as of September 15, 2025. Its market cap has increased by 11.52% in one year.

Market Cap
8.93B
Enterprise Value
9.90B
1-Year Change
11.52%
Ranking
#975
Category
Mid-Cap
Stock Price
$76.33

Market Cap Chart

Since March 16, 2004, Halozyme Therapeutics's market cap has increased from $8.10M to $8.93B, an increase of 110,122.40%. That is a compound annual growth rate of 38.50%.

History

DateMarket Cap% Change
Sep 12, 20258.99B47.87%
Dec 31, 20246.08B24.59%
Dec 29, 20234.88B-36.54%
Dec 30, 20227.69B35.91%
Dec 31, 20215.66B-1.95%
Dec 31, 20205.77B122.23%
Dec 31, 20192.60B22.85%
Dec 31, 20182.11B-26.67%
Dec 29, 20172.88B125.43%
Dec 30, 20161.28B-42.33%
Dec 31, 20152.22B83.35%
Dec 31, 20141.21B-29.21%
Dec 31, 20131.71B126.01%
Dec 31, 2012756.30M-23.30%
Dec 30, 2011986.10M23.98%
Dec 31, 2010795.40M47.84%
Dec 31, 2009538.00M17.96%
Dec 31, 2008456.10M-17.36%
Dec 31, 2007551.90M6.38%
Dec 29, 2006518.80M469.48%
Dec 30, 200591.10M-13.07%
Dec 31, 2004104.80M1,193.83%
Mar 16, 20048.10M-
View and export this data all the way back to 2004. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

CompanyMarket Cap
Eli Lilly and Company678.14B
Johnson & Johnson428.83B
AbbVie385.71B
UnitedHealth Group319.26B
AstraZeneca247.84B
Novo Nordisk242.99B
Novartis AG240.09B
Abbott Laboratories232.75B
Market Cap Rankings